All Type of News
KFDA approves two homegrown drugs
Demonstrating the strength of the country's R&D capabilities, the Korea Food and Drug Administration Wednesday approved two Korean drugs – Shinpoong Pharmaceutical’s anti-malarial drug ‘Pyramax’ and JW Pharmaceutical’...
Monopoly on OTC drugs by pharmacists needed to ensure public safety
A dispute has arisen over the planned introduction next month of a government-imposed review of over-the-counter (OTC) drugs.
The Ministry of Health and Welfare has already designated 48 relatively safe non-prescri...
Controversy brewing over KPMA president’s remarks
A controversy surrounding the recent remarks made by Korea Pharmaceutical Manufacturers Association (KPMA) president Lee Kyung-ho in a MBC radio program, Thursday, is growing.
Lee said in the program that the local...
Anti-ulcerant market edges up 3.7% in July
The domestic anti-ulcerant market increased by 3.7 percent to 70.1 billion won in July, compared with the same month last year due to the government’s merciless price cuts.
The government lowered the prices of 2,39...
Korea’s medicine business at a crossroads
With retail prices of 8,776 drugs out of the total 14,410 listed on the national health insurance that are expected to fall about 17 percent on average beginning next year following a set of government-led reforms, ma...
Bacchus-F to please Dong-A
With the possible reclassification of 48 over-the-counter (OTC) drugs as “quasi-drugs,” pharmaceutical companies, many of which saw their sales fall following a government crackdown on kickbacks given to doctors or ph...
NHIC seeking price cuts of 10 drugs
The National Health Insurance Corp. says it will negotiate with drug manufacturers the prices of 10 medicines, including Roche’s Herceptin injection and Novartis’s Aclasta injection until October 11.
Under the curr...
KFDA approves new anti-impotency drug
The Korea Food and Drug Administration (KFDA) yesterday approved the domestic sale of Zepid (avanafil), a new type of anti-impotency drug.
Created by JW Pharmaceutical, Zepid is Korea’s third homegrown erectile dys...
Drug firms want equitable support from government
In order to soften the blow of massive drug price cuts on drug makers, the Ministry of Health and Welfare unveiled plans Friday to support innovative pharmaceutical companies to be selected based on their research and...
Dong-A to expand production volume of Bacchus-D
Dong-A Pharmaceutical Co. has unveiled its tentative plan to extend its production line of the popular drink Bacchus-D in Dalsung plant in Daegu to give a wider access in supermarkets and 24-hour convenient stores.
...
